Home2025August13Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis August 13, 2025betadmin None #stockmarket #breaking
Bitcoin Trading Signals [URL] For Full Data 2025-02-05 00:37:11 $BTC #Bitcoin #Blockchain #TradingSignlas Bitcoin Trading Signals Summary Buy Signals: 2025-01-26 05:08:33.097000: Buy at 105124.49967086142 2025-01-26 16:03:43.471000: Buy at 104946.39234830825 2025-01-27 15:03:49.422000: Buy at…
As Musk Assumes Deregulation Role, Tesla Racks Up Pollution Violations – The Wall Street Journal $TSLA #Tesla None #stockmarket #breaking